- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07700186
Skin Barrier Function in Women Using UV Nail Lamps
Comparison of Objective Skin Barrier Function Parameters Between Women Who Use and Women Who Do Not Use UV Nail Lamps for Nail Treatments
The goal of this observational study is to compare objective parameters of skin barrier function between healthy adult women who regularly use UV lamps during nail treatments and women who do not use UV lamps.
The main questions it aims to answer are:
- Do women who regularly use UV lamps for nail treatments show differences in skin barrier function compared to women who do not use UV lamps?
- Are transepidermal water loss, skin hydration, and erythema associated with regular exposure to UV lamps used for nail treatments?
- Does the duration of UV lamp use influence skin barrier function parameters?
Researchers will compare women who regularly use UV lamps during nail treatments with women who have natural nails and do not regularly expose their hands to UV lamps.
Participants will:
- Attend a single study visit.
- Complete a short questionnaire regarding nail care habits and duration of UV lamp use.
- Undergo non-invasive measurements of skin barrier function on the hands, including transepidermal water loss, skin hydration, and erythema assessments.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Josipa Bukić
- Phone Number: +385917933753
- Email: jbukic@mefst.hr
Study Locations
-
-
-
Split, Croatia, 2100
- Recruiting
- University of Split School of Medicine
-
Contact:
- Josipa Bukić
- Phone Number: +385917933753
- Email: jbukic@mefst.hr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Healthy adult women (≥18 years of age)
- Willing and able to provide written informed consent
- Willing to complete the study questionnaire
Exclusion Criteria:
- Active skin diseases (e.g., psoriasis, vitiligo, or other dermatological conditions)
- Allergic contact dermatitis
- Pregnancy or breastfeeding
- Use of topical or systemic corticosteroids, immunosuppressive drugs, or antihistamines
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Regular UV Nail Lamp Users
Healthy adult women who regularly undergo nail treatments involving exposure to UV lamps.
|
|
Non-Users of UV Nail Lamps
Healthy adult women who do not regularly undergo nail treatments involving exposure to UV lamps and have natural nails.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Transepidermal Water Loss (TEWL)
Time Frame: Day 1 (single study visit)
|
Skin barrier function will be assessed by measuring transepidermal water loss using a Tewameter TM 300 probe.
Values will be expressed in g/m²/h
|
Day 1 (single study visit)
|
|
Change in Skin Hydration
Time Frame: Day 1 (single study visit)
|
Hydration of the stratum corneum will be assessed using a Corneometer CM 825 probe.
|
Day 1 (single study visit)
|
|
Change in Skin Erythema
Time Frame: Day 1 (single study visit)
|
Skin erythema will be assessed using a Mexameter MX 18 probe.
|
Day 1 (single study visit)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Josipa Bukić, University of Split, School of Medicine
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2181-198-03-04-26-0035
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.